Caffeine: A Potential Protective Agent Against Cognitive Decline in Alzheimer's Disease. [electronic resource]
- Critical reviews in eukaryotic gene expression 2018
- 67-72 p. digital
Publication Type: Journal Article; Review
1045-4403
10.1615/CritRevEukaryotGeneExpr.2018021391 doi
Alzheimer Disease--complications Caffeine--therapeutic use Central Nervous System Stimulants--therapeutic use Cognitive Dysfunction--drug therapy Humans Protective Agents--therapeutic use